TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Enterprise Value (2024 - 2025)

TFA Therapeutics (RAJAF) posted Enterprise Value of $1.0 billion for Q4 2025, up 11.28% on a QoQ basis from $916.7 million in Q4 2024, and up 11.28% year-over-year from $916.7 million in Q4 2024.

Analysis

TFA Therapeutics (RAJAF) Enterprise Value (2024 - 2025) Analysis & Trends

TFA Therapeutics has reported Enterprise Value for 2 years, with the latest figure at $1.0 billion in Q4 2025.

  • On a quarterly basis, Enterprise Value rose 11.28% year-over-year to $1.0 billion in Q4 2025; TTM through Dec 2025 was $1.0 billion, a 11.28% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 11.28% from the prior year.
  • Enterprise Value was $1.0 billion for Q4 2025 at TFA Therapeutics, up from $916.7 million in the prior quarter.
  • The five-year high for Enterprise Value was $1.0 billion in Q4 2025, with the low at $916.7 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Colgate Palmolive 70.23 Bn 68.86 Bn 3.30 Bn
2 Kenvue 34.13 Bn 33.02 Bn 2.30 Bn
3 Kimberly Clark 32.73 Bn 31.77 Bn 1.60 Bn
4 Bath & Body Works 3.77 Bn 2.98 Bn 692.00 Mn
5 Prestige Consumer Healthcare 2.27 Bn 2.21 Bn -
6 Perrigo 1.89 Bn 1.49 Bn 313.90 Mn
7 Herbalife 1.28 Bn 905.45 Mn 1.03 Bn
8 Edgewell Personal Care 1.24 Bn 840.59 Mn 242.50 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn -
10 Honest Company 586.90 Mn 481.00 Mn 40.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.02 Bn
Dec 31, 2024 916.70 Mn